Companies · Other Health Care

Restor Metabolix Inc

Carrollton · Other Health Care

Diligence memoA one-page analyst read on Restor Metabolix Inc — recommendation, valuation, rhythm, risks.
$4.0M
Total raised · real
2
Rounds
0.3×
Latest step-up
Top 40%
Sector rank · raised
Seed
Latest stage · inferred · Sat Oct 15 2022 00:00:00 GMT+0000 (Coordinated Universal Time)

Restor Metabolix Inc looks fair against its niche peers and is at-risk on financing cadence.

Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.

Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.

Fair
  • Modeled value is 0.77× the median modeled value of Seed Other Health Care companies in 2022–2024 (244 peers) — value vs value, same stage and era.
  • Within the normal band (77% of peer median) for its niche.
At-risk
  • Last raise 3.7 yr ago; this sector typically re-raises about every 14 months.
  • Past due for a raise versus sector cadence — watch for distress or a bridge.
Leadership

No named principal in this company's public records yet — see all operators below.

Explore how these operators interlock with other companies in the operator network.

Where it sits in Other Health Care

Restor Metabolix Inc is one of 5377 Other Health Care companies tracked from Carrollton. By capital raised it ranks mid-pack (ahead of 61% of sector peers), and in the long tail by modeled valuation est..

Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.

As reported in public records reported — not modeled.

US
Jurisdiction
$5M–$25M
Issuer revenue
Rule 506(c)
Reg D exemption
2020
Year incorporated
2022-10-15
First sale
Amount raised vs valuation, by round

Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.

Amount raised · realModeled valuation · estCumulative funded · real
$0$13M$25M$38M$50MSeed · 2021-11-08 Raised $3.0M (real) Modeled valuation $42M (est)$3.0M$42MSeed2021Seed · 2022-10-15 Raised $1.0M (real) Modeled valuation $9.3M (est)$1.0M$9.3MSeed2022+$1.0MCumulative $4.0M

The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.

Financing ladder & sequence gaps
Seed$3.0M · 2021
Seed extension$1.0M · 2022

Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.

Modeled valuation trajectory
$9.3M
Base estimate est.
$846K
Conservative case
$39.2M
Upside case
$5.0M
Modeled post-money

Round size and date are reported; the stage label is inferred from round size (latest is Seeda $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.

Seed · modeled $41.6M · 2021-11-082021Seed · modeled $9.3M · 2022-10-152022
Model inputs · modeled:benchmark-stage-stepup-v1
20%
Dilution assumption
Implied ownership sold in the financing.
38%
Survival probability
17% low · 58% high
1.54×/yr
Annual markup
2.01×/yr upside case
3.7 yr
Elapsed time used
3.7 yr actual, capped for stale marks
health care
Sector profile
Adjusts growth and survival by industry.
Financing rhythm
11 mo
Avg between rounds
$4.3M/yr
Capital velocity
4.6 yr
On record since
2021
First round
2
Rounds on file
How it compares to the market

Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.

Total raised — vs sector median (real $, all stages) 1.6× above median
This company$4.0M
Sector median$2.4M
Latest round — vs other Seed rounds in sector (real $, this stage) 0.6× of median
This company$1.0M
Sector median$1.7M
Modeled value — vs sector median (estimate, all stages) 0.4× of median
This company$9.3M
Sector median$22.1M

Raised more than 61% of sector peers (real $). Modeled value above 33% of peers (estimate).

Niche peers — same stage & era

A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #154 of 244.

This companyCohort peer
$1.0M$10.0M$100.0M$1.0M$10.0MCapital raised (log)Elmntri LLC · Seed Raised $4.0M · modeled $46.1M (est)Atreo, Inc. · Seed Raised $3.8M · modeled $42.1M (est)descendantsDNA, Inc. · Seed Raised $3.4M · modeled $40.8M (est)Westover Project Investor LLC · Seed Raised $4.0M · modeled $40.0M (est)Dentulu Inc · Seed Raised $6.4M · modeled $37.7M (est)Emmacare.com LLC · Seed Raised $3.0M · modeled $37.2M (est)IR-Med, Inc. · Seed Raised $5.4M · modeled $37.0M (est)SDH Parent 2 LLC · Seed Raised $3.0M · modeled $36.7M (est)TecTraum, Inc. · Seed Raised $7.8M · modeled $36.7M (est)DBN BCS II Investments, LLC · Seed Raised $3.0M · modeled $34.0M (est)USRC Baldwin Hills, LLC · Seed Raised $2.8M · modeled $34.0M (est)Flex Operating Room, Inc. · Seed Raised $6.2M · modeled $31.9M (est)Restor Metabolix Inc (this company) Raised $4.0M · modeled $9.3M (est)Restor Metabolix Inc
CompanyStageRaised · realValue · estvs peer med.
Elmntri LLCSeed$4.0M$46.1M3.83×
Atreo, Inc.Seed$3.8M$42.1M3.50×
descendantsDNA, Inc.Seed$3.4M$40.8M3.40×
Westover Project Investor LLCSeed$4.0M$40.0M3.33×
Dentulu IncSeed$6.4M$37.7M3.13×
Emmacare.com LLCSeed$3.0M$37.2M3.10×
IR-Med, Inc.Seed$5.4M$37.0M3.08×
SDH Parent 2 LLCSeed$3.0M$36.7M3.05×
TecTraum, Inc.Seed$7.8M$36.7M3.05×
DBN BCS II Investments, LLCSeed$3.0M$34.0M2.83×
USRC Baldwin Hills, LLCSeed$2.8M$34.0M2.82×
Flex Operating Room, Inc.Seed$6.2M$31.9M2.65×
Restor Metabolix Inc this companySeed$4.0M$9.3M0.77×
Full financing history

Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.

StageAmount · realAnnouncedPost-money · estValue · estConf.
Seed$3.0M2021-11-08$15.0M$41.6M90%
Seed$1.0M2022-10-15$5.0M$9.3M90%
What happened at each round

Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.

  1. Seed$3.0M2021-11-08
    • First recorded raise — entered as Seed.
  2. Seed$1.0M2022-10-15
    • Raised 11 mo later, in step with the ~14 mo sector norm.
    • Round 3.0× smaller than the prior — bridge or down round.
    • Switched to Rule 506(c) (was Rule 506(b)).
Intelligence
2023 ~Q3
Modeled next raise · ~11mo cadence
$1.0M
Modeled next size est.range $1.0M$1.6M
0.3×
Last step-up
$4.3M/yr
Capital velocity

Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.

Key people & operators

Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.

PersonRoleAlso runsTied since
JEFF SMITH16 other2021-11
Jeffrey A. Smith4 other2022-10
Jouko Rissanen3 other2021-11
Charles Edwards2 other2021-11
Jouko J Rissanen2 other2022-10
Michael Rozmajzl2 other2021-11
Charles K Edwards2022-10
Christopher Gaunder2021-11
Christopher K Gaunder2022-10
Dan Dunn2021-11
Demarco J Bell2022-10
Michael H Rozmajzl2022-10
Nicholas J Reiter2022-10
Nicholas Reiter2021-11
Randy Crawford2021-11
Randy J Crawford2022-10
Tom Greene2021-11
William Gafford2021-11
William H Gafford2022-10
Registry & provenance

Restor Metabolix Inc is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.

United States
Country of record
US
Jurisdiction
1901338
SEC CIK
2020
Incorporated
Similar companies

Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.

CompanySectorStageRaised · realValue · estWhy similar
GenomOncology, LLCOther Health CareSeed$5.8M$79.3Mnetwork1 shared operator · same sector · same stage
Amendia IncOther Health CareSeries A$14.2M$85.5Mnetwork2 shared operators · same sector
Tissue Regeneration Technologies LlcOther Health CarePre-Seed$1.0M$1.6Mnetwork2 shared operators · same sector
Cedar Park Surgery Center, LLCOther Health CareSeed$1.9M$3.8Mnetwork1 shared operator · same sector · same stage
Carewear CorpOther Health CareSeed$4.0M$7.7Msame sector · same stage
Center at Eden Hill, LLCOther Health CareSeed$4.0M$7.5Msame sector · same stage
Duxlink Health, Inc.Other Health CareSeed$4.0M$7.5Msame sector · same stage
Las Cruces Healthcare Management, LLCOther Health CareSeed$4.0M$7.5Msame sector · same stage
Semantically similar

Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.

CompanySectorStageValue · estMatch
Metabolon, IncOther Health CareSeries B$42.1M87%
RESTOR3D, Inc.Other Health CareSeries C$522.3M87%
Remedtx, Inc.Other Health CarePre-Seed$1.4M84%
MetaModix, Inc.Other Health CareSeed$4.2M83%
MedRx Global, Inc.Other Health CarePre-Seed$27.7M83%
MetaCan, Inc.Other Health CareSeries A$5.9M83%
Vascugenix Inc.Other Health CarePre-Seed$3.0M82%
Medsender, Inc.Other Health CareSeries A$29.8M82%
Frequently asked
How much funding has Restor Metabolix Inc raised?
Restor Metabolix Inc has raised approximately $4.0M in disclosed capital across 2 recorded financing rounds, aggregated from public filings.
What is Restor Metabolix Inc's estimated valuation?
Provath's modeled valuation for Restor Metabolix Inc is approximately $9.3M (modeled range $846K–$39.2M). This is an algorithmic estimate derived from round sizes and same-niche peers — not a quoted or reported figure.
What funding stage is Restor Metabolix Inc at?
Restor Metabolix Inc's latest modeled financing stage is Seed. Its most recent recorded round closed around Sat Oct 15.
What does Restor Metabolix Inc do and where is it based?
Restor Metabolix Inc operates in the Other Health Care sector, based in Carrollton.
Explore related

See where Restor Metabolix Inc sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.

Is this your company?

If you work at Restor Metabolix Inc, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.

Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.